Filtered By:
Procedure: Transplants
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 5394 results found since Jan 2013.
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID ‑19 vaccination in liver transplant recipients (Review)
Exp Ther Med. 2023 May 3;25(6):291. doi: 10.3892/etm.2023.11990. eCollection 2023 Jun.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (Sars-CoV-2) infection has significantly affected immunocompromised individuals and subsequently, liver transplant recipients (LTRs). Early in the course of pandemic, this vulnerable population was prioritized for vaccination, after obtaining encouraging data about the vaccination benefits on disease severity and mortality. As the published knowledge was mainly supported from studies which were limited to the healthy population, the present review summarizes the data from the literat...
Source: Experimental and Therapeutic Medicine - May 19, 2023 Category: General Medicine Authors: Aikaterini Gkoufa Maria Saridaki Vasiliki Epameinondas Georgakopoulou Demetrios A Spandidos Evangelos Cholongitas Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
COVID ‑19 vaccination in liver transplant recipients (Review)
Exp Ther Med. 2023 May 3;25(6):291. doi: 10.3892/etm.2023.11990. eCollection 2023 Jun.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (Sars-CoV-2) infection has significantly affected immunocompromised individuals and subsequently, liver transplant recipients (LTRs). Early in the course of pandemic, this vulnerable population was prioritized for vaccination, after obtaining encouraging data about the vaccination benefits on disease severity and mortality. As the published knowledge was mainly supported from studies which were limited to the healthy population, the present review summarizes the data from the literat...
Source: Experimental and Therapeutic Medicine - May 19, 2023 Category: General Medicine Authors: Aikaterini Gkoufa Maria Saridaki Vasiliki Epameinondas Georgakopoulou Demetrios A Spandidos Evangelos Cholongitas Source Type: research
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
